ESTRO 36 Programme book and exhibition guide

KLAAS BREUR AWARD

Claus Rödel Department of Radiotherapy and Oncology, University of Frankfurt Frankfurt, Germany

Claus Rödel (born in 1966) graduated from Erlangen Medical School, Germany, in 1994, and completed his medical speciality training degree in radiation oncology in 2002. He was attending physician and consultant at the Department of Radiation Therapy, University of Erlangen, Germany, until 2006. In 2007, he was appointed Director and Chair of the Department of Radiotherapy and Oncology at the University of Frankfurt, Germany. Since 2008, he has also served as Clinical Director of the Comprehensive Cancer Centre (UCT) of the University Hospital of Frankfurt, and is a principal investigator within the German Cancer Consortium (DKTK). His main research interests focus on combined modality treatment, including targeted therapies, for patients with rectal and bladder cancer, as well as molecular prediction of tumour response. As speaker of the German Rectal Cancer Study Group he led several phase I-III clinical trials to establish and optimise chemoradiotherapy for rectal cancer patients. His scientific work has been honoured with the Herman-Holthusen Award of the German Society of Radiation Oncologist (DEGRO), the Clinical Science Award of ARO, and the German Cancer Society’s (DKG) Award for the best clinical trial in 2015. He also serves as member of the ESTRO Clinical Committee and is Director of the ESTRO teaching course for lower gastrointestinal cancers.

Claus Rödel

Programme and Exhibition Guide | ESTRO AWARDS

39